University of Sussex
Browse

File(s) not publicly available

Discovery and Management of Adverse Drug Reactions: The Nomifensine Hypersensitivity Syndrome, 1977-1986

journal contribution
posted on 2023-06-07, 23:18 authored by John Abraham, Courtney Davis
Taking the antidepressant, nomifensine, this article focuses on the discovery and management of adverse drug reactions (ADRs) manifested in doctors' spontaneous post-marketing reports. Company-friendly experts, free-lancer research scientists, public servant physicians and regulatory scientists are shown to have made distinct contributions to ADR discovery. However, institutional and international fragmentation delayed synthesis of ADR reports into unambiguous discovery. Qualitative and quantitative interpretative standards of what counted as ADR discovery affected regulatory warning systems and decisions about when to withdraw a drug from the market. The timing and definition of an ADR as `irreversible or `rare was, in part, a function of the uncertainty and estimation criteria chosen by the party managing the discovery. UK regulators accepted relatively low levels of uncertainty, so the timing of discovery, warnings and regulatory action was relatively late, but US regulators chose higher thresholds of uncertainty about discovery when interpreting the need to warn of suspected serious ADRs. The implications of these practices for the founding ideals of a post-marketing `early warning system are considered.

History

Publication status

  • Published

Journal

Social History of Medicine

ISSN

0951-631X

Issue

1

Volume

23

Page range

153-173

Pages

21.0

Department affiliated with

  • Sociology and Criminology Publications

Full text available

  • No

Peer reviewed?

  • Yes

Legacy Posted Date

2012-02-06

Usage metrics

    University of Sussex (Publications)

    Categories

    No categories selected

    Exports

    RefWorks
    BibTeX
    Ref. manager
    Endnote
    DataCite
    NLM
    DC